Safety and efficacy of daratumumab monotherapy in lupus nephritis refractory to conventional and rescue therapies

被引：0
作者：
Roccatello, Dario
Caniggia, Ilaria
Ceruti, Cecilia
Longo, Roberta
Nescis, Lorenzo
Sciascia, Savino
Fenoglio, Roberta
机构：
[1] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Nephrol & Dialysis Unit, Turin, Italy
[2] Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, Ctr Immuno Rheumatol & Rare Dis CMID, Turin, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.364
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
#2244
引用
收藏
页数：1
相关论文
共 50 条
[31]   Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis [J].
Weidenbusch, Marc ;
Roemmele, Christoph ;
Schroettle, Angelika ;
Anders, Hans-Joachim .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) :106-111
[32]   Two cases demonstrating thalidomide’s efficacy in refractory lupus nephritis [J].
Rita Raturi ;
Avani A. Patel ;
John D. Carter .
Clinical Rheumatology, 2017, 36 :725-728
[33]   Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis [J].
Raturi, Rita ;
Patel, Avani A. ;
Carter, John D. .
CLINICAL RHEUMATOLOGY, 2017, 36 (03) :725-728
[34]   EFFICACY VERSUS SAFETY OF PREDNISONE IN LUPUS NEPHRITIS SINCE 1988 [J].
Petri, M. ;
Magder, L. S. ;
Bichile, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 :181-181
[35]   Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis [J].
Zhou, Tianbiao ;
Lin, Shujun ;
Yang, Shen ;
Lin, Wenshan .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 :857-869
[36]   Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus [J].
Josefina Cortés-Hernández ;
Gabriela Ávila ;
Miquel Vilardell-Tarrés ;
Josep Ordi-Ros .
Arthritis Research & Therapy, 14
[37]   Efficacy and safety of lenalidomide for refractory cutaneous lupus erythematosus [J].
Cortes-Hernandez, Josefina ;
Avila, Gabriela ;
Vilardell-Tarres, Miquel ;
Ordi-Ros, Josep .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (06)
[38]   Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma [J].
Plesner, Torben ;
Arkenau, Hendrik-Tobias ;
Lokhorst, Henk M. ;
Gimsing, Peter ;
Krejcik, Jakub ;
Lemech, Charlotte ;
Minnema, Monique C. ;
Lassen, Ulrik ;
Laubach, Jacob P. ;
Ahmadi, Tahamtan ;
Yeh, Howard ;
Guckert, Mary E. ;
Feng, Huaibao ;
Brun, Nikolai Constantin ;
Lisby, Steen ;
Basse, Linda ;
Palumbo, Antonio ;
Richardson, Paul G. .
BLOOD, 2014, 124 (21)
[39]   SAFETY AND EFFICACY OF DARATUMUMAB WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR RELAPSED, REFRACTORY MULTIPLE MYELOMA [J].
Plesner, T. ;
Arkenau, H. T. ;
Lokhorst, H. M. ;
Gimsing, P. ;
Krejcik, J. ;
Lemech, C. ;
Minnema, M. C. ;
Lassen, U. ;
Ahmadi, T. ;
Yeh, H. ;
Guckert, M. ;
Brun, N. C. ;
Lisby, S. ;
Basse, L. ;
Palumbo, A. ;
Richardson, P. G. .
HAEMATOLOGICA, 2014, 99 :104-104
[40]   Safety and Efficacy of Daratumumab Monotherapy in Patients with Heavily Pretreated Relapsed and Refractory Multiple Myeloma: Final Results from GEN501 and Sirius [J].
Usmani, Saad Z. ;
Nahi, Hareth ;
Weiss, Brendan M. ;
Bahlis, Nizar J. ;
Belch, Andrew ;
Lokhorst, Henk M. ;
Voorhees, Peter M. ;
Richardson, Paul G. ;
Uhlar, Clarissa ;
Wang, Jianping ;
Qi, Ming ;
Lonial, Sagar .
BLOOD, 2017, 130
12345